ATG5 and acute myeloid leukemia: AML is a hierarchical malignancy originating from LSCs, and a compromise in the viability of LSCs could explain the mechanism by which Atg5 deletion prolongs the survival of mice burdened with MLL-AF9-driven AML during primary transplantation.